对瘤微环境的全面分析揭示了预后性ceRNA网络,与肉瘤中的免疫透有关
Dongliang Leng1, Ziyi Yang1, Heng Sun1,2
1CRDA, Faculty of Health Sciences, University of Macau, Taipa, Macau.
概括
这项研究确定了竞争的内源RNA (ceRNA) 网络作为肉瘤的有希望的生物标志物,为改善早期检测和治疗策略提供了对瘤微环境调节的新见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 肉瘤是一种流行的儿童癌症,具有侵略性行为,对有效治疗构成挑战.
- 确定准确的生物标志物对于早期瘤检测和预后至关重要.
研究的目的:
- 根据瘤免疫透水平 (TIIL) 来表征瘤亚型.
- 构建一个与预后相关的竞争性内源性RNA (ceRNA) 网络,用于研究肉瘤瘤微环境 (TME) 中的分子规则.
- 确定关键的监管分子及其对TME的影响.
主要方法:
- 构建和分析一个ceRNA网络,包括miRNAs,lncRNAs和mRNAs的子网络.
- 在 silico 分析, in vivo 和 in vitro 实验用于验证.
- 在TME中确定分子的生物学作用的调查.
主要成果:
- 一个包含5个miRNA,3个lncRNA和10个mRNA的ceRNA子网络被确定为塑造肉瘤TME的关键.
- 研究人员发现,全HDAC抑制剂Trichostatin A有潜力调节TME并抑制肉瘤的生长.
- 鉴定到的网络提供了对瘤TME.ceRNA参与的全面了解.
结论:
- 开发的ceRNA网络作为肉瘤的一个有前途的生物标志物.
- 这项研究为肉瘤TME内的ceRNA调节提供了新的视角.
- 研究结果支持针对已确定网络的潜在治疗策略.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558


